4.0 Article

Nivolumab and relatlimab for the treatment of melanoma

Journal

DRUGS OF TODAY
Volume 59, Issue 2, Pages 91-104

Publisher

PROUS SCIENCE, SAU-THOMSON REUTERS
DOI: 10.1358/dot.2023.59.2.3509756

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available